Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database
As a result, GLP- 1's primary effects include decreasing body weight, protecting against cardiovascular disease, and lowering fasting and postprandial blood glucose levelsall of which are therapeutic targets in T2DM
It may resolve your hypothyroid symptoms like hair loss , fatigue , and brain fog but it usually doesnt lead to weight loss
Ultimately, a shift toward personalized, mechanism-based management may significantly reduce the burden of PTDM and improve graft and patient outcomes
Common adverse effects include nausea, vomiting, diarrhea, and constipation, which are generally dose-dependent and often improve with continued use